Measles, a vaccine-preventable disease, is extremely contagious given that it can be spread via airborne transmission (1). A susceptible person who has face-to-face contact with an infected person has a 90% likelihood of developing the disease (2). Measles is still common in many parts of the world, particularly in countries with developing economies. Approximately 20 million cases are estimated to occur globally each year, with 89,780 deaths from measles in 2016 – mostly children under the age of 5 years, despite the availability of a safe and effective vaccine (3).
Measles is caused by a virus of the paramyxovirus family and it is contracted through direct contact and through the air. Measles is a human disease and is not known to occur in animals (4). Accelerated immunization activities have had a major impact on reducing measles deaths. From 2000 to 2016, vaccination against measles prevented 20.4 million deaths. Global measles deaths have decreased by 84% from an estimated 550,100 in 2000 to 89,780 in 2016 (5).
The measles vaccination is highly effective, safe and relatively cost-effective (6), and has interrupted measles transmission in most parts of the world (7), although high-risk areas remain in Africa and southern Asia. Population susceptibility to measles is dependent on the uptake of Measles 1 and Measles 2, vaccine effectiveness, immunity as a result of prior infection and protection by maternal antibodies in infants. Therefore, using these factors, it is possible to estimate population susceptibility to measles using a well-defined formula (8).
The Eastern Mediterranean Region has made substantial progress towards achieving measles elimination and reducing the burden of Measles disease. By 2008, measles deaths had decreased to 7000 deaths from 96,000 in 2000 - a reduction of 93%. The number of confirmed measles cases decreased from about 88,000 in 1998 to 11,295 in 2011 (9). The World Health Organization (WHO)- UNICEF Global Immunization Vision and Strategy (GIVS) achieved a reduction in measles deaths by 90% in 2010 compared to the year 2000 (9, 10). During the period 1998–2010, reported measles cases in the Region decreased by 77%, from 89,478 cases in 1998 to 10,072 in 2010. However, during 2011–2013, regional progress slowed and the number of reported measles cases increased more than 2-fold to reach 20,884 cases in 2013, with the occurrence of large outbreaks in several countries. Around 90% of the reported measles cases during the period 2011–2013 were from 5 countries: Afghanistan, Pakistan, Somalia, Sudan and Yemen. With this resurgence of measles in some countries, the EMR’s target of measles elimination by 2015 is not likely to be achieved.
In Pakistan, the Expended Program on Immunization was started in 1978, in which initially six vaccines were included, namely childhood tuberculosis, poliomyelitis, diphtheria, pertussis, tetanus and measles containing vaccine-1 (MCV-1), while measles containing vaccine-2 (MCV-2) was added in 2009. The World Health Organization’s statistics give more than 24,000 measles cases with 300 deaths in Pakistan in the year 2017 (11), out of which 93 were from Balochistan (5, 12). The estimated MCV1 coverage in Pakistan increased from 57% in 2000 to 76% in 2017, and the estimated MCV2 coverage increased from 30% in 2009 to 45% in 2017, while Balochistan remained the lowest in the country coverage with MCV1 from 17% in 2009 to 33% in 2017 and MCV2 from 8% in 2009 to 34% in 2017 (11). The MCV-1 coverage of the district was 22% in 2009 to 43% in 2017 and MCV-2 coverage from 19% in 2009 to 39% in 2017. The expanded program of immunization schedule in the country is given in table below (Table 1).
Table 1
Routine Immunization Schedule in Pakistan
Age of child | Vaccination |
---|---|
At Birth | OPV 0, BCG |
6 Weeks | OPV 1, PENTA 1, PCV 1, Rota Virus 1 |
10 Weeks | OPV 2, PENTA 2, PCV 2, Rota Virus 2 |
14 Weeks | OPV 3, PENTA 3, PCV 3, IPV |
9 Months | Measles 1 (MCV-1) |
15 Months | Measles 2 (MCV-2) |
Source: Expanded Program of Immunization Pakistan (13) |
This study was the account of the measles outbreak in Nasirabad district in 2018. Nasirabad district is situated at South East of the Balochistan province of Pakistan. The bordering districts are Sibi, Kachhi, Jhal Magsi, Jaffarabad and Sohbat pur. The Population is highly mobile with seasonal migration for agriculture purposes. Pat Feeder Canal, a tributary from Sindh River serves the purpose of agriculture. According to censes 2017, the district has a population of 490,538 with an area of 3,387 km2 comprising of three Tehsils and 33 union councils (14).
On 16 February 2018, the District Health officer (DHO) of Nasirabad reported 16 suspected measles cases from the nomadic population of Dera Murad Jamali town to provincial disease surveillance and response unit Quetta and requested for an investigation. A FELTP (Field Epidemiology and laboratory Training Program) fellow was deputed by Director General Health Services (DGHS) Balochistan on 17 February to investigate the outbreak, evaluate risk factors and recommend control measures.
H0: There is no association between nomadic populations having zero routine immunizations (measles containing vaccine) and the development of a measles outbreak.
H1: There is an association between nomadic populations having zero routine immunizations (measles containing vaccine) and the development of a measles outbreak.
A purposive sampling technique was adopted and a case control study was planned and conducted. Matched pairs for age and sex controls (1:2) were taken. Case was defined as “acute onset of generalized maculopapular rash and fever with one of the following: cough or coryza or conjunctivitis between 29 January to 20 February 2018 in a resident of nomadic population in Dera Murad Jamali town”. Controls were selected against the cases from the same community. To understand the outbreak and the perspective of the community, a combined meeting session with district administration and community members in the area was conducted. Hospital records were reviewed and house to house surveys were conducted using a pre structured questionnaire. Information on socio-demographics, clinical signs and symptoms, vaccination status, risk factors and disease outcome were collected and analyzed. Vaccination status (MCV-1 “measles containing vaccine 1” and MCV-2 “measles containing vaccine 2”) along with other antigens was verified based on respondents’ recall and vaccination card. Apart from active case finding, verbal autopsy was carried out by visiting the addresses of deceased children. The data was entered, cleaned and coded. The descriptive statistics were calculated, tables/graphs were generated and inferential statistics were calculated using Epi Info 7.0 version. The odds of getting disease in Measles 1 versus no measles 1 and Measles 2 versus no measles 2 were calculated. All significance was reported at confidence interval of 95% and p-value less than 0.05. The risk factors were coded as 0= No and 1= Yes. Community members from nomadic populations who contracted measles were included in the study and controls from same nomadic community who have not contracted measles while community outside nomadic population were excluded. Due to confined nomadic community and lab constraint only five samples were collected for Immunoglobulin M (IgM) serology.
A total of 49 cases (overall AR= 0.17%) including five deaths (Case Fatality Rate=10.2%) were identified. Sixty percent (n=33) of cases from the total were detected through the active search in community. The median age of the cases was three years with an age range one to ten years, while the median age group of controls were four years with an age range one to eleven years. Among the cases, 61% (n=30) were males and 46% (n=19) were females, while out of 98 controls, 67% (n=66) were males while 33% (n=32) were females. During active case finding, majority 69% (n=34) of cases found were among the age group 0 to 4 years, followed by 23% (n=11) from 5 to 9 years of age, and 8% (n=4) from 10 to 14 years of age (Table 2).
Table 2
Attack rates with Specific Age group (n=49)
Age Groups (Years) | Cases (n=49) | Percentage (%) | Total population of that Age Group | Attack Rates / 1000 Pop |
---|---|---|---|---|
0-4 | 34 | 69 | 4305 | 7.9 |
5-9 | 11 | 23 | 4519 | 2.4 |
10-14 | 4 | 8 | 3532 | 1.1 |
The routine vaccination assessment survey revealed that among the cases, 71% (n=35) of children were unimmunized for any routine antigen and 29% (n=14) were partially immunized. In controls, 32% (n=31) were unimmunized for any routine immunization. From the cases 4% (n=2) were vaccinated for MCV1 and none of the cases were vaccinated for MCV2. In controls, 34% (n=33) were vaccinated for MCV1, while 17% (n=17) were vaccinated for MCV2. In cases, out of the total none have the EPI card, while in controls 40% (n=39) verified through EPI card while 60% (n=59) responded on recall history. Seventy three percent (n=36) of respondents responded that a vaccinator did not visit their homes to vaccinate their children, 16% (n=8) were unaware about the routine vaccinations, and 10% (n=5) were having misconceptions and misbeliefs regarding routine immunization. The laboratory results showed that out of five blood samples all were positive for measles IgM antibodies.
On bivariate analysis, a significant statistical association was found between the nomadic population having zero routine immunization and the development of measles (Table-3).
Table 3
Risk Factors Association
Risk factor | OR | 95% CL | P value |
---|---|---|---|
Nomadic Population | 2.85 | 1.83-4.42 | <0.0021 |
Mother’s Education | 0.92 | 0.72-1.97 | <0.0401 |
Measles 1 | 0.045 | 0.0010-0.0099 | <0.0051 |
Measles 2 | 0.00033 | 0.00081-0.00213 | <0.0041 |